The estimated Net Worth of Benjamin Drew Davies is at least $5.32 Million dollars as of 23 August 2018. Mr Davies owns over 16,148 units of Natus Medical Inc stock worth over $4,686,286 and over the last 8 years he sold NTUS stock worth over $0. In addition, he makes $629,967 as Exec. VP & CFO at Natus Medical Inc.
Sign up
Mr Davies NTUS stock SEC Form 4 insiders trading
Mr has made over 7 trades of the Natus Medical Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently he exercised 16,148 units of NTUS stock worth $532,238 on 23 August 2018.
The largest trade he's ever made was exercising 33,333 units of Natus Medical Inc stock on 31 January 2017 worth over $1,098,656. On average, Mr trades about 4,557 units every 28 days since 2016. As of 23 August 2018 he still owns at least 142,181 units of Natus Medical Inc stock.
You can see the complete history of Mr Davies stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr. Benjamin Drew Davies biography
Benjamin Drew Davies is the Exec. VP & CFO at Natus Medical Inc.
What is the salary of Mr Davies?
As the Exec. VP & CFO of Natus Medical Inc, the total compensation of Mr Davies at Natus Medical Inc is $629,967. There are 4 executives at Natus Medical Inc getting paid more, with Jonathan Kennedy having the highest compensation of $3,335,550.
How old is Mr Davies?
Mr Davies is 55, he's been the Exec. VP & CFO of Natus Medical Inc since . There are 11 older and 6 younger executives at Natus Medical Inc. The oldest executive at Natus Medical Inc is Kenneth Ludlum, 66, who is the Independent Director.
What's Mr Davies's mailing address?
Benjamin's mailing address filed with the SEC is C/O NATUS MEDICAL INCORPORATED, 3150 PLEASANT VIEW ROAD, MIDDLETON, WI, 53562.
Insiders trading at Natus Medical Inc
Over the last 5 years, insiders at Natus Medical Inc have traded over $3,793,396 worth of Natus Medical Inc stock. The most active insiders traders include Dong Chune Christopher Chung, Joshua Levine und Jonathan Kennedy. On average, Natus Medical Inc executives and independent directors trade stock every 70 days with the average trade being worth of $543,972. The most recent stock trade was executed by Dong Chune Christopher Chung on 9 December 2021, trading 11,787 units of NTUS stock currently worth $243,755.
What does Natus Medical Inc do?
Natus Medical Incorporated is a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages.
What does Natus Medical Inc's logo look like?
Complete history of Mr Davies stock trades at Extreme Networks und Natus Medical Inc
Natus Medical Inc executives and stock owners
Natus Medical Inc executives and other stock owners filed with the SEC include:
-
Jonathan Kennedy,
President, Chief Executive Officer, Director -
B. Drew Davies,
Chief Financial Officer, Executive Vice President -
Austin Noll,
Executive Vice President and Chief Commercial Officer -
D. Christopher Chung,
Vice President - Quality, Regulatory Affairs and Chief Medical Officer -
Benjamin Drew Davies,
Exec. VP & CFO -
Austin F. Noll III,
Exec. VP & Chief Commercial Officer -
Dr. D. Christopher Chung M.D.,
VP of Quality, Regulatory Affairs & Chief Medical Officer -
Dr. D. Christopher Chung,
VP of Quality, Regulatory Affairs & Chief Medical Officer -
Barbara Paul,
Independent Chairman of the Board -
Kenneth Ludlum,
Independent Director -
Lisa Heine,
Independent Director -
Joshua Levine,
Independent Director -
Thomas Joseph Sullivan,
Pres, CEO & Director -
Alice Schroeder,
Independent Director -
Thomas Sullivan,
Independent Director -
Ilan Daskal,
Independent Director -
William Hill,
General Counsel -
Sean Langan,
Vice President of Global Operations -
Lisa Paul,
Vice President and Chief People Officer -
Douglas Balog,
VP, Gen. Counsel & Sec. -
Lisa Paul,
Chief People Officer & VP -
Ivan Pandiyan,
VP of Global R&D -
Seán Langan,
VP Global Operations -
Eric Guerin,
Director -
Bryant M Moore,
Director